SLUG expression is an indicator of tumour recurrence in high-grade endometrial carcinomas
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SLUG expression is an indicator of tumour recurrence in high-grade endometrial carcinomas
Authors
Keywords
-
Journal
HISTOPATHOLOGY
Volume 69, Issue 3, Pages 374-382
Publisher
Wiley
Online
2016-03-22
DOI
10.1111/his.12971
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endometrial cancer
- (2016) Philippe Morice et al. LANCET
- The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma
- (2015) Rocco Cappellesso et al. HISTOPATHOLOGY
- Cooperative actions of p21WAF1 and p53 induce Slug protein degradation and suppress cell invasion
- (2014) J. Kim et al. EMBO REPORTS
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention
- (2014) Samantha Kaufhold et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
- (2014) David N. Church et al. JNCI-Journal of the National Cancer Institute
- Signaling mechanisms of the epithelial-mesenchymal transition
- (2014) D. M. Gonzalez et al. Science Signaling
- Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer
- (2013) Yoshimichi Tanaka et al. CANCER BIOLOGY & THERAPY
- Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas
- (2013) Tina A. Ayeni et al. GYNECOLOGIC ONCOLOGY
- Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees
- (2013) Joyce N. Barlin et al. GYNECOLOGIC ONCOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer—A clinical and pathological evaluation
- (2011) Martin A. Voss et al. GYNECOLOGIC ONCOLOGY
- Patterns of p53 immunoreactivity in endometrial carcinomas: ‘all or nothing’ staining is of importance
- (2011) W Glenn McCluggage et al. HISTOPATHOLOGY
- p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma
- (2010) Seung-Oe Lim et al. FEBS LETTERS
- The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
- (2010) Martin Köbel et al. JOURNAL OF PATHOLOGY
- ERα signaling through slug regulates E-cadherin and EMT
- (2010) Y Ye et al. ONCOGENE
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas
- (2009) David G. Mutch GYNECOLOGIC ONCOLOGY
- p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
- (2009) Shu-Ping Wang et al. NATURE CELL BIOLOGY
- ERα suppresses slug expression directly by transcriptional repression
- (2008) Yin Ye et al. BIOCHEMICAL JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now